Carcinosarcomas (Malignant Mixed Mullerian Tumor) of the Uterus: Advances in Elucidation of Biologic and Clinical Characteristics

被引：74

作者：

Kernochan, Lauren E. ^{[1
]}

Garcia, Rochelle L. ^{[1
]}

机构：

[1] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2009年 / 7卷 / 05期

关键词：

Malignant mixed Mullerian tumor; carcinosarcoma; uterus; GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-III TRIAL; FEMALE GENITAL-TRACT; UTERINE CARCINOSARCOMAS; ENDOMETRIAL CARCINOMAS; HISTOGENESIS; IFOSFAMIDE; COMPONENTS; OVARIAN; DIFFERENTIATION;

D O I：

10.6004/jnccn.2009.0037

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Carcinosarcoma of the uterus (malignant mixed Mullerian tumor [MMMT]) is an uncommon, typically extremely aggressive neoplasm histologically composed of malignant epithelial and mesenchymal (stromal) elements. Although the literature contains some debate, most authors now agree that most MMMTs derive from sarcomatous differentiation in a high-grade carcinoma. This article reviews the clinical and histopathologic features of this interesting neoplasm, with particular emphasis on recent data supporting MMMTs as primarily epithelial malignant neoplasms with areas of mesenchymal/spindle cell differentiation. (JNCCN 2009;7:550-557)

引用

页码：550 / 556

页数：7

共 34 条

[11] Endometrial carcinoma [J].

Di Cristofano, Antonio ;

Ellenson, Lora Hedrick .

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2007, 2 :57-85

[12] Wilms tumor gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray [J].

Dupont, J ;

Wang, X ;

Marshall, DS ;

Leitao, M ;

Hedvat, CV ;

Hummer, A ;

Thaler, H ;

O'Reilly, RJ ;

Soslow, RA .

GYNECOLOGIC ONCOLOGY, 2004, 94 (02) :449-455

[13]

Fujii H, 2000, CANCER RES, V60, P114

[14] Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group study [J].

Homesley, Howard D. ;

Filiaci, Virginia ;

Markman, Maurie ;

Bitterman, Pincas ;

Eaton, Lynne ;

Kilgore, Larry C. ;

Monk, Bradley J. ;

Ueland, Frederick R. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :526-531

[15] Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus [J].

Inthasorn, P ;

Carter, J ;

Valmadre, S ;

Beale, P ;

Russell, P ;

Dalrymple, C .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (04) :348-353

[16]

JEFFERS MD, 1995, MODERN PATHOL, V8, P701

[17] Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: A genetic study with special reference to histogenesis [J].

Jin, Z ;

Ogata, S ;

Tamura, G ;

Katayama, Y ;

Fukase, M ;

Yajima, M ;

Motoyama, T .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (04) :368-373

[18] Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: Comparative molecular analysis of epithelial and mesenchymal components [J].

Kounelis, S ;

Jones, MW ;

Papadaki, H ;

Bakker, A ;

Swalsky, P ;

Finkelstein, SD .

HUMAN PATHOLOGY, 1998, 29 (01) :82-87

[19]

Lacey J., 2009, Robboy's Pathology of the Female Reproductive Tract

[20] Malignant mixed mullerian tumor of fallopian tube with multiple distinct heterologous components [J].

Lim, BJ ;

Kim, JW ;

Yang, WI ;

Cho, NH .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (04) :690-693

← 1 2 3 4 →